Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast Cancer
A completed clinical trial describing the breast cancer patient population, treatment, and results in Indian patients receiving combinations…
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: Aging Mammary Stem Cells and Breast Cancer Prevention [Phase 2]
Phase 2 clinical trial on aging mammary stem cells for breast cancer prevention was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-04Clinical Trial Update: A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast Cancer [Phase 2]
Phase 2 study evaluating talazoparib, radiotherapy, and atezolizumab in gBRCA1/2-negative, PD-L1 positive metastatic triple-negative breast …
-
CLINICAL_TRIALS trial_result · 2023-12-04Clinical Trial Update: A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity [Phase 2]
A Phase 2 clinical trial evaluating monosialic gangliosides to prevent neurotoxicity from albumin-bound paclitaxel in early breast cancer ha…
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Vitamin D and Calcium Supplementation in Breast Cancer [Phase 2, Phase 3]
A clinical trial update investigating the effect of vitamin D and calcium supplementation in patients with breast cancer across Phase 2 and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: Regional Anesthesia for Modified Radical Mastectomy With Axillary Lymph Node Dissection [Phase 3]
A Phase 3 clinical trial evaluating regional anesthesia techniques for modified radical mastectomy with axillary lymph node dissection in br…
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer [Phase 3]
Phase 3 clinical trial investigating Salovum™ and SPC-Flakes™ to mitigate abemaciclib-induced gastrointestinal toxicity in early breast canc…
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating breast-conserving surgery plus radiation therapy for patients with multiple ipsilateral breast canc…
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating paclitaxel plus radiation therapy in women with stage II or III breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: Evaluate the Meritup Oral Solution to Decrease Fatigue in Metastatic Breast Cancer Patients Receiving Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating Meritup oral solution to decrease fatigue in metastatic breast cancer patients undergoing chemotherapy.
-
CLINICAL_TRIALS trial_result · 2023-11-27Clinical Trial Update: Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer [Phase 2]
A Phase 2 trial evaluating fulvestrant with or without bortezomib in patients with operable locally advanced or metastatic estrogen receptor…
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast Cancer [Phase 2]
Phase 2 trial evaluating the biological effects of adding zoledronic acid to pre-operative chemotherapy in breast cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer [Phase 3]
A Phase 3 trial evaluating a fasting mimicking diet program to improve chemotherapy outcomes in hormone receptor-positive, HER2-negative bre…
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer. [Phase 2]
Phase 2 clinical trial update examining pre-operative endocrine therapy with and without Prometrium (progesterone) in postmenopausal women w…
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: A Study of Abemaciclib in Indian Women With Advanced Breast Cancer [Phase 4]
Phase 4 trial update of abemaciclib in Indian women with advanced breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer [Phase 1, Phase 2]
Clinical trial update for SHR6390 in combination with letrozole, anastrozole, or fulvestrant in HR-positive, HER2-negative advanced breast c…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib [Phase 2]
Phase 2 trial evaluating the incidence and severity of diarrhea in patients with HER2-positive breast cancer treated with trastuzumab and ne…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: A Phase II Study to Explore the Safety, Tolerability, and Preliminary Antitumor Activity of Sitravatinib Plus Tislelizumab or Combination With Nab-paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC) [Phase 2]
A Phase 2 clinical trial assessing safety, tolerability, and preliminary antitumor activity of Sitravatinib plus Tislelizumab or with Nab-pa…
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: Dalpiciclib Combination With Fulvestrant and Compound Gossyfol Acetate Tablets in Women With CDK4/6 Inhibitor-refractory HR-positive HER-2 Negtive Metastatic Breast Cancer: a Phase 2 Clinical Trial. [Phase 2]
A Phase 2 trial evaluating dalpiciclib in combination with fulvestrant and compound gossyfol acetate tablets for women with HR-positive, HER…
-
CLINICAL_TRIALS trial_result · 2023-11-14Clinical Trial Update: Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer [Phase 3]
Phase 3 trial comparing 4 cycles versus 6 cycles of TC (docetaxel + cyclophosphamide) as adjuvant chemotherapy for early breast cancer with …
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca [Phase 2]
Phase 2 trial evaluating neoadjuvant pembrolizumab plus decitabine followed by standard neoadjuvant chemotherapy for locally advanced HER2-n…
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer [Phase 2]
Phase 2 pilot trial investigating oxytocin and microRNA identification in nipple aspirate fluid, serum, and tissue from women with breast ca…
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer [Phase 3]
Phase 3 trial comparing Utidelone with AC versus Docetaxel with AC as neoadjuvant therapy for HER2-negative breast cancer is ongoing or not …
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Reducing Pain and Disability After Breast Cancer Surgery [NA]
This clinical trial update reports a completed study aimed at reducing pain and disability after breast cancer surgery, with results posted …
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Neoadjuvant TCHP Versus THP in Patients With HER2-positive Breast Cancer (neoCARHP Study) [Phase 3]
Phase 3 trial comparing neoadjuvant TCHP versus THP in HER2-positive breast cancer (neoCARHP); status not specified.